Abiraterone Acetate Tablet
Product Images NDC 51407-503

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 51407-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-503-12ol (Abiraterone 125mg)

Label for Abiraterone Acetate 125 mg tablets, showing the product name, strength, and dosage form. The label indicates a package count of 120 tablets and Rx only. It includes manufacturer details as Golden State Medical Supply (gsms), handling warnings, storage instructions, a barcode, and a QR code. The label advises swallowing tablets whole and dispensing patient information.*

FDA Label Image

Image Description (Yonsa 1)

Chemical structure of abiraterone acetate showing its molecular configuration including a steroidal backbone, acetate group, and a pyridine ring.*

FDA Label Image

Image Description (Yonsa 2)

A survival curve graph comparing % survival over time in months between Abiraterone Acetate and placebo groups. The x-axis shows time to death in months, and the y-axis shows percent survival. Two curves indicate survival trends, with a legend differentiating Abiraterone Acetate (solid line) and placebo (dashed line). Below the x-axis are numbers representing the population at risk for each group at various time points.*

FDA Label Image

Image Description (Yonsa 3)

A survival curve chart comparing the percentage of subjects without death over months from randomization for abiraterone acetate versus placebo. The x-axis represents months from 0 to 60, and the y-axis shows the percentage of subjects without death from 0% to 100%. Two survival lines are depicted, one for placebo and one for abiraterone acetate, illustrating differences in survival over time.*

FDA Label Image

Image Description (Yonsa 4)

A Kaplan-Meier curve comparing the percentage of subjects without radiographic progression or death over time (months from randomization) between abiraterone acetate and placebo groups. The x-axis represents months from randomization, and the y-axis shows the percentage of subjects free of progression or death. The solid line depicts abiraterone acetate, and the dashed line depicts placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.